Intervention
Axitinib
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 9 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
9 shownPhase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 MutationsNCT05904730 · 2023-07-11
COMPLETEDStudy of KN046 in Subjects With Advanced Non-Small Cell Lung CancerNCT05420220 · 2022-07-26
COMPLETEDA Study to Evaluate the Bioavailability of Pembrolizumab (MK-3475) Via Subcutaneous (SC) Injection of Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180) [MK-3475A] In Advanced Solid Tumors (MK-3475A-C18)NCT05017012 · 2021-09-21
COMPLETEDStudy of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)NCT04585815 · 2020-11-10
TERMINATEDStudy of PF-07265807 in Participants With Metastatic Solid Tumors.NCT04458259 · 2020-09-24
TERMINATEDA Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell CarcinomaNCT04522323 · 2020-08-05
ACTIVE_NOT_RECRUITINGSurvival Prolongation by Rationale Innovative GenomicsNCT03386929 · 2017-11-29
TERMINATEDAntiandrogen Therapy With or Without Axitinib Before Surgery in Treating Patients With Previously Untreated Prostate Cancer With Known or Suspected Lymph Node MetastasisNCT01409200 · 2012-03-26
COMPLETEDA Study of Axitinib in Advanced Carcinoid TumorsNCT01435122 · 2011-10-25
COMPLETEDCommon conditions
Advanced Non-small Cell Lung Cancer1Advanced or Metastatic Solid Tumors1Advanced Renal Cell Carcinoma1BRCA Mutation1Breast Cancer1Breast Neoplasms1Carcinoid Tumor1Carcinoma, Non-Small-Cell Lung1HER-2 Protein Overexpression1HER2-negative Breast Cancer1HER2-positive Breast Cancer1Metastatic Malignant Neoplasm in Lymph Node1Neoplasm Metastasis1Non-small Cell Lung Cancer Metastatic1Non-small Cell Lung Cancer Stage IIIB1Ovarian Cancer1Ovarian Neoplasms1Prostate Ductal Adenocarcinoma1Stage III Prostate Adenocarcinoma AJCC v71Stage IV Prostate Adenocarcinoma AJCC v71
Leading sponsors
Trial status mix
COMPLETED5
TERMINATED3
ACTIVE_NOT_RECRUITING1
Phase mix
PHASE16
PHASE25
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.